#WAOpioidTrial Day 18 has begun this morning! As suspected the unscheduled trial break was because one of the key players got COVID. It was the judge!😳 He's back now.
State has resumed their redirect of their witness, former DEA Ruth Carter.
AM link:
#WAOpioidTrial We're spending a ton of time looking at distributor reports from 2008 (and such) about percentage of controlled substances ordered by specific pharmacies. With zero context about the population(s) those locations served, proximity to cancer centers, surgery, etc.
It's not possible to call something a "red flag" w/o having that context. State's argument is distributors should've flagged all kinds of things w/o guidance, regulatory requirements etc.
Former DEA Ruth Carter: "To reiterate: the slides I made had bullet points but they didn't reflect things .. which had changed.."
Right. You made slides for the state which portrayed only SOME of the facts, to make the defense look bad. For $2million.
Got it.
#WAOpioidTrial Gnarly legal debate about the admissibility of a DOJ settlement letter with McKesson from 2014 ... after much back and forth, the judge allows it.
Interestingly it's allegedly to rebut something said from 2008? I think? It was a lot to follow.
#WAOpioidTrial State just tried to sneak in new evidence on redirect; defense objects and the judge sustains.
It seems as if state is trying to bring up lots of stuff to "generally rebut this vague feeling of .. ." ?
While I find the law fascinating some of this is tedious.
#WAOpioidTrial state is reviewing individual threshold change requests for pharmacies from 2010 as evidence.
Reminder that DEA had oversight on every manufacturer, distributor, prescriber, pharmacy, and pharmacy order. Every step of the way.
Yet DEA claims zero responsibility.
Even if a distributor could have done better with this process - not ONE rx opioid was dispensed without a medical professional. And a patient requesting it.
#WAOpioidTrial Aaaand we're adjourned for the lunch break.
Lots more of state trying to get documents admitted to help rebut things, lots of decisions going both ways. It's a lot. My respect for court staff and counsel has increased immensely. Back in 90 minutes!
#WAOpioidTrial And we are back. Here's this afternoon's link.
We resume with a legal argument about a Touhy request made by defense, which apparently was denied by DOJ ... let's watch.
For those of us not lawyers - this is a Touhy Request:
"Getting Documents and Testimony from the United States When it is Not a Party to the Case"
And now we are back to state's redirect of Ruth Carter.
Not for nothing ... but state was supposed to keep their redirect to under 5 hours, if I recall correctly. And their redirect started partially on 1/5. Hmm. 👀
#WAOpioidTrial And now we're debating how much of Ms. Carter's work history vs. public record is admissible - and the Judge has had the witness step out while the parties argue it.
This is interesting!
#WAOpioidTrial Ooooh Judge sustains the defense's objection - the witness is not allowed to testify to .. um ... some legal stuff which I'm not going to rewind the feed to capture exactly accurately.
That seem like a big win for the defense, IMHO.
#WAOpioidTrial We've moved on to Ms. Carters *personal opinion* about 'how these companies felt about their responsibilities to maintain effective controls against diversion" - her opinion, to be clear, is NOT the same what as DEA required all those year. Just .. what.
#WAOpioidTrial And state is finally done with redirect. We're moving on to re-cross (or whatever it's called).
Starting with McKesson's counsel.
#WAOpioidTrial Sidebar: We're in a new courtroom today; the King County Judicial system reassigns court assignments annually (it was last week). This is a new room for this trial.
The tech team is battling some WICKED feedback squeal intermittently in this new room. Aieee. 😬
#WAOpioidTrial Whoops I got distracted on a thing, sorry. We moved on to re-cross (?) of Ms. Carter by McKesson's counsel.
At one point he asks her about a letter from DEA's RAN saying "DEA is updating the Diversion Control Manual in 2009, until then use these temporary rules"
Which got me wondering - DID the DEA actually publish a new Diversion Control Manual in 2009? Let's go look.
So like . . . the DEA currently isn't sharing a Diversion Control Manual. It is "currently updating all of the manuals".
But ... surely they DID have manuals there? But when? And when were they pulled?
La la la folks I give you: The Wayback Machine! The DEA *did* have a bunch of manuals shared publicly on this stuff as recently as 2018. This is what was there, then:
The most recently-shared manual for the distributors regarding orders/distribution - if I'm not mistaken - was the ARCOS registrant handbook - most recently published in 1997. Last revised August 1997.
What I find interesting about this is that multiple members of the DEA have stated under oath during various opioid trials about how the distributors (and pharmacies, and manufacturers) SHOULD have known better, should have done better - but it seems like ... maybe .. tbd
Is it possible that these companies were largely complying with all currently-available guidance and regulations at the time?
It's also possible there's guidance which DEA doesn't publicly share - but I dunno.
Seems sketchy to pull all DEA manuals during ongoing litigation?
By which I mean: If the DEA cannot officially declare what regulations must be followed, which best guidance could be followed - can they now state under oath that these companies were not able to read their minds back then? That they didn't instantly evolve processes constantly?
#WAOpioidTrial We're looking at old DEA letters - where they say things like "DEA will no longer accept" <stuff>, which darn well implies that THEY USED TO ACCEPT stuff, right? So anytime prior to that letter, DEA *MAY* have accepted or tolerated certain things.
DEA used to have far looser regs and guidelines 'back in the day'. Which means the distributors were largely on their own about their processes and procedures. Can we now hold the distributors liable for that? I can't imagine how. Bleah.
McKesson to Carter:
"Are you aware of any DEA guidance saying that records should be retained for the life of the customer?"
Carter (who has said REPEATEDLY on the record that distributors SHOULD be keeping records FOREVER): <many words, frankly non-responsive>
McK: re-asks
McKesson: Do you recall saying those exact words (cites date, time, line from the transcript on Jan. 5th of this year)?
Long story short: It has been her OPINION this whole time, but she keeps stating it on the record as if it were a DEA requirement. Which it never was.
#WAOpioidTrial Aaand we're wrapping up for the day. More Ms. Carter re-cross tomorrow, but first a little clarification about handing exhibits to parties and to the sharefile for the official record, looked like a fight but it's been gracefully resolved. And that's it for today!
• • •
Missing some Tweet in this thread? You can try to
force a refresh
#WAOpioidTrial Day 20 is about to begin; here's the AM link for today.
SEVERAL big issues to be decided upon this morning by the Judge; who will have reviewed a few briefs from counsel this morning before court adjourns. WHAT will happen?? Stay tuned.
#WAOpioidTrial The first big question: Will the Judge allow these subjective surveys to be admitted - dancing around whether Dr. Banta-Green is a fact witness (which means the surveys COULD be hearsay) or if he's a dang expert (which he clearly is, but not for this trial?)
#WAOpioidTrial The judge - sort of bemused about how state keeps referring to Dr. Banta-Green as a 'fact witness' - has asked both parties for BRIEF oral arguments about admitting the surveys.
Hopefully defense brings up that it was a teeny survey of one county by syringe users.
#WAOpioidTrial resumed earlier this morning - I'm feeling bleah so I'm late on the updates. We finally, finally wrapped up testimony/cross/re-everything with Ruth Carter with only three things which stood out. Also here's the AM link until lunch.
1st: Counsel inquired about various things Ms. Carter had missed or excluded or got wrong in specific documents. There were quite a few things in various redirect/cross where that happened ... all of which painted the defense negatively. Hmm
#WAOpioidTrial Second: When Ms. Carter was asked about a benzo in a document, she replied: "Yes but that's not an opioid, it's a benzodiazepine, and those are also widely sought after by DRUG ABUSERS."
She has continually called people who use RX or illicit substances this.
#WAOpioidTrial Day 15 has just begun. In a confusing twist, yesterday's trial stream started on the channel about 15 mins before court started. So we NOW join today's trial in progress at THIS link, below. McKesson continuing cross with DEA's Carter.
"Has DEA ever publicly stated the appropriate amount of medically-necessary opioids needed for the nation, or for WA?"
Well no - I'm not a medical doctor. I couldn't make that calculation.
CORRECT.
McKesson's counsel is asking Carter about earlier trial depo transcript - DEA regs changed 'drastically' in 2006-2007, so that instead of distributors notifying DEA of suspicious orders AND still shipping them, they should hold those orders. That was standard prior to 2006-2007.
#WAOpioidTrial Day 14 has begun; this morning's link below.
We resume with former DEA unit chief Ruth Carter, state's witness, still on the stand IRL discussing various alleged issues with the 3 defendants' diversion control issues over the years.
Oh for . . . 'Cardinal stepped up reporting suspicious orders (undefined) to DEA in 2012; but if a pharmacy's order was held bc it they'd reached their order threshold, but then the threshold reset because time passed - THEY WOULD STILL SHIP NEW ORDERS.' Right. Because ....
The only reason that order was suspicious/held was because it exceeded their previously-determined order limit. Not because it was "suspicious". Then when that pharmacy needed to fill scripts PER USUAL, they placed their usual order. DEA wanted patients to suffer/go without? 🤯
#WAOpioidTrial Day 13 has begun! We open this morning with state re-arguing some objections which did not go their way last week on foundation. Let's watch and see how this goes. The three prongs (apparently) are:
Authentic
Relevant
Admissible
Judge Scott has retiterated many times - and pretty much begged state to stop saying - it's not about authenticity, it's about foundation & relevance. Literally Judge said "please stop saying authenticity" AND THEN STATE SAID IT AGAIN and the Judge literally put a "wait" hand up.
Literally state is continuing to stay AUTHENTIC - it had the company's logo on it on every page .. .. .
While IANAL . .. I think the judge is going to maintain his earlier rulings on the series of objections from last week. Interesting stuff.
A few words about the 2005 WA State L&I opioid study - upon which the 2016 CDC Opioid RX guidelines were launched. This study was limited to a very specific group of people injured on the job in WA (as opposed to those with chronic or progressive illness). #cdcowgchat#cdcGov 1/8
There were 32 "definitely, probably" opioid-related deaths from 1996-2002 in WA, & 12 more 'possibly' or avg 7 deaths/yr. 85% were men. 69% were smokers. 8 of the deaths included illicit drugs (meth, cocaine, heroin). 5 more alcohol. In other words: Polypharma drug toxicity. 2/8
Only 14 of these workers received Sched 2-4 opioids within 3 months of death. From where did these other 30 workers obtain opioids later? Were any of them screened for a history of non-medical use prior to treatment? Previous non-fatal overdose? Mental health issues? 3/8